Dr. Goy on Novel Therapies at the JTCC Conference

Andre Goy, MD, MS
Published Online: Tuesday, October 11, 2011
Andre Goy, MD, MS, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, discusses how novel treatment options have revolutionized treatment for patients with non-small cell lung cancer, a disease that used to be considered “beyond surgery.”

Novel therapies, new characterizations of tumors, and a more personalized approach to treating these tumors will be discussed at the upcoming New Frontiers In The Management of Solid and Liquid Tumors conference at John Theurer Cancer Center at Hackensack University Medical Center, November 3-4, 2011.

Online CME Activities
Free CME from PER
Advances in Multiple Myeloma
Cancer Summaries and Commentaries™: Update from Chicago: Castrate Resistant Prostate Cancer and Advanced Melanoma
Community Practice Connections™: Novel Perspectives in Personalizing EGFR-Targeted Therapy in NSCLC: Frontline and Overcoming Resistance
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Gynecologic Cancers
More Reading
$auto_registration$